RYKAX (RYKAX) Stock Price & Analysis
RYKAX (RYKAX) rose 0.53% to USD 116.67 as of July 26, 2026 at 01:24 UTC, according to Nexqual real-time market data.
RYKAX last closed at USD 116.05; the session ranged USD 116.67–116.67 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 92.16–119.09 (NAS). Source: Nexqual, July 26, 2026 at 01:24 UTC.
Key Statistics (as of July 26, 2026 at 01:24 UTC)
| Price | USD 116.67 |
|---|---|
| Change | ▲ 0.53% (up) |
| Previous Close | USD 116.05 |
| Open | USD 116.67 |
| Day Range | USD 116.67 – 116.67 |
| 52-Week Range | USD 92.16 – 119.09 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (RYKAX)
Nexqual's technical model rates RYKAX "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 26, 2026 at 01:24 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.94 (neutral) |
| vs SMA50 | Above (USD 110.77) |
| MACD | 1.65 (positive) |
Financial Health Score (RYKAX)
Nexqual rates RYKAX's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 01:24 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYHAX | Rydex Series Fds, Health Care F | USD 122.53 | ▲ 1.36% |
| RYCAX | Rydex Series Fds, Consumer Prod | USD 96.51 | ▼ 1.01% |
| RYFAX | Rydex Series Fds, Financial Ser | USD 95.52 | ▲ 0.4% |
| RYOAX | Rydex Series Fds, Biotechnology | USD 67.96 | ▲ 0.53% |
| RYSAX | Rydex Series Fds, Electronics F | USD 801.52 | ▼ 5.15% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 01:24 UTC. This page is informational and not investment advice.